Zobrazeno 1 - 10
of 87
pro vyhledávání: '"Krahl, A."'
Autor:
Benjamin Mayer, Patrick Gerner, Carsten Posovszky, Teresa Seitel, Henning Lenhartz, Michael Radke, Elke Lainka, Klaus-Michael Debatin, Sibylle Koletzko, Sarah Ehrenberg, J. Vermehren, Andreas Krahl, Klara Frivolt, Stefan Trenkel, Luana Cagol, Thomas Mertens
Publikováno v:
Vaccine. 38:1810-1817
Background and aims Immunosuppressed patients are at risk of severe infections with vaccination preventable diseases. We evaluated vaccination rate and immunity of children and adolescents with inflammatory bowel disease (IBD) and autoimmune hepatiti
Autor:
Christian Seitz, Joerg Mittelstaet, Jana Hau, Selina Reiter, Clara Illi, Verena Kieble, Fabian Engert, Britta Drees, Giulia Bender, Daniel Atar, Ann-Christin Krahl, Philipp Knopf, Sarah Schroeder, Nikolas Paulsen, Alexander Rokhvarguer, Sophia Scheuermann, Elena Rapp, Anna-Sophia Mast, Armin Rabsteyn, Sabine Schleicher, Stefan Grote, Karin Schilbach, Manfred Kneilling, Bernd Pichler, Dominik Lock, Bettina Kotter, Sandra Dapa, Stefan Miltenyi, Andrew Kaiser, Peter Lang, Rupert Handgretinger, Patrick Schlegel
Publikováno v:
OncoImmunology, Vol 10, Iss 1 (2021)
Chimeric antigen receptor (CAR)-T therapy holds great promise to sustainably improve cancer treatment. However, currently, a broad applicability of CAR-T cell therapies is hampered by limited CAR-T cell versatility and tractability and the lack of ex
Autor:
Patrick Schlegel, Christian Seitz, Daniel Atar, Sarah Schroeder, Jana Hau, Leticia Quintanilla-Martinez, Manuela Martella, Rupert Handgretinger, Bernd J. Pichler, Philipp Knopf, Sabine Schleicher, Karin Schilbach, Ann-Christin Krahl, Peter Lang, Manfred Kneilling
Publikováno v:
OncoImmunology, Vol 9, Iss 1 (2020)
Oncoimmunology
Oncoimmunology
Expression of the disialoganglioside GD2 has been identified as a marker antigen associated with a breast cancer stem-like cell (BCSC) phenotype. Here, we report on the evaluation of GD2 as a BCSC-specific target antigen for immunotherapy. GD2 expres
Autor:
Samih H. Nasr, Erika Bracamonte, Amy N. Sussman, Leslie Krahl, Bijin Thajudeen, Anjuman Howlader
Publikováno v:
Kidney International Reports
Kidney International Reports, Vol 2, Iss 6, Pp 1233-1237 (2017)
Kidney International Reports, Vol 2, Iss 6, Pp 1233-1237 (2017)
Autor:
Christian Jakob, Christian Junghanss, Sebastian Schwind, Volker Schmidt, Niklas Zojer, Kolija Reifenrath, Andreas Hochhaus, Christoph Kahl, Dietger Niederwieser, Haifa Kathrin Al-Ali, Georg Maschmeyer, Thomas Heinicke, Herbert G. Sayer, Norma Peter, Rainer Krahl, Thomas Fischer, Sebastian Scholl, Axel Florschütz, Ute Hegenbart, Michael Cross, Hans-Heinrich Wolf, Christian Niederwieser
Publikováno v:
Blood. 134:1358-1358
Introduction: Outcome of patients (pts) with refractory AML or following relapse is considered dismal and usually reported as refractory/relapsed. Here we analyzed long term outcome of refractory and relapsing pts separately over a 10 year (y) period
Autor:
Marius Bill, Cornelia Becker, Rainer Krahl, Hannah Tessenow, Christian Pfrepper, Georg Franke, Sebastian Schwind, Vladan Vucinic, Madlen Jentzsch, Thomas Zehrfeld, Madlen Holzvogt, Dietger Niederwieser, Sabine Leiblein, Marc Andrea, Simone Heyn, Thoralf Lange, Bruno Holzvogt, Thomas Schliwa, Maik Schwarz, Wolfram Pönisch
Publikováno v:
Journal of cancer research and clinical oncology. 143(10)
Patients with light chain myeloma frequently have a light chain tubular cast nephropathy, which can lead to severe renal impairment. In the present retrospective study, bortezomib was combined with other active substances like bendamustine and predni
Autor:
Thoralf Lange, Haifa Kathrin Al-Ali, Sabine Leiblein, Dietger Niederwieser, Nadezda Basara, Elvira Edel, R. Krahl, Malvina Bourgeois, Wolfram Poenisch
Publikováno v:
Bone Marrow Transplantation. 46:1296-1302
With the increasing age of patients undergoing allogeneic hematopoietic cell transplantation (HCT), the age of matched related sibling donors (MRDs) is expected to increase. Donor safety and the impact of donors' age on mobilization, collection of pe
Autor:
Christine Mauz-Körholz, Dietger Niederwieser, Jean Krutmann, Thoralf Lange, R. Krahl, Dieter Körholz, U Banning
Publikováno v:
Bone Marrow Transplantation. 35:691-697
Assessment of risk factors for acute graft-versus-host disease (aGvHD) might help in tailoring the intensity of prophylactic immunosuppression after allogeneic stem cell transplantation (SCT), thereby decreasing the relapse rate in leukaemia patients
Autor:
Rainer Krahl, Christine Günther, Scarlet Musiol, Dietger Niederwieser, Sabine Leiblein, Haifa Kathrin Al-Ali, Michael W. Deininger, Thomas Köhler, Thoralf Lange, Iris Van Hoomissen
Publikováno v:
Blood. 101:2152-2155
Imatinib induces remissions in approximately 30% of patients with chronic myeloid leukemia (CML) in myeloid blast crisis (M-BC). Because most patients eventually relapse, allogeneic stem cell transplantation (SCT) in remission offers the best chance
Autor:
Dietger Niederwieser, Thomas Friedrich, Michael W. Deininger, Christina Franke, Evelin Hennig, Thomas Bumm, Erika Schmidt, Knut Krohn, Patricia Shepherd, Christel Müller, R. Krahl, Sabine Leiblein, Haifa Kathrin Al-Ali
Publikováno v:
Blood. 101:1941-1949
Chronic myelogenous leukemia (CML) is characterized by the presence of a Bcr-Abl fusion protein with deregulated tyrosine kinase activity that is required for maintaining the malignant phenotype. Imatinib, a selective inhibitor ofBcr-Abl, induces maj